Standard BioTools Inc. received a Nasdaq deficiency notice on April 20, 2026, for failing to meet the $1.00 minimum bid price requirement, triggering a 180-day compliance period.
Key takeaways
Nasdaq notified the Company of non-compliance with the $1.00 minimum bid price rule on April 20, 2026.
The Company has 180 calendar days, until October 19, 2026, to regain compliance.
Compliance requires maintaining a $1.00 closing bid price for at least 10 consecutive business days.
The Company's stock continues to trade on The Nasdaq Global Select Market under ticker 'LAB' without interruption.
The Company may be eligible for an additional 180-day compliance period if it transfers to The Nasdaq Capital Market.